Story perspectives

Analysts Rate Ionis and Immunocore as Strong Buys

11/10/2025

47 9

Summary

Story summary

Ionis Pharmaceuticals carries a Buy rating from William Blair's Myles Minter, with a target of $81.40 and price $73.55, signaling a 10.6% upside; Oppenheimer sets a $90.00 target.
Immunocore Holdings receives a Buy rating from H.C. Wainwright's Patrick Trucchio with a $100.00 target; the stock trades at $33.50 and has an average target of $66.50, implying a 110.0% upside.
Analysts rate both Ionis Pharmaceuticals and Immunocore Holdings as Strong Buy.

1 of 1

Story summary

Ionis Pharmaceuticals carries a Buy rating from William Blair's Myles Minter, with a target of $81.40 and price $73.55, signaling a 10.6% upside; Oppenheimer sets a $90.00 target.
Immunocore Holdings receives a Buy rating from H.C. Wainwright's Patrick Trucchio with a $100.00 target; the stock trades at $33.50 and has an average target of $66.50, implying a 110.0% upside.
Analysts rate both Ionis Pharmaceuticals and Immunocore Holdings as Strong Buy.